Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Net product revenues by geography
Net product revenues by geography — United States (U.S.) ($M) ($M)
Vertex Pharmaceuticals Net product revenues by geography: $7,549M in FY2025, up 12.9% from a year earlier. That is the highest of the 17 years on record here.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-13) ↗
Reported in Form 10-Q / 10-K Segment & Geographic Information Note.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net product revenues by geography — United States (U.S.) ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 7,549 | +12.9% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 6,685 | +10.7% | Form 10-K (filed 2026-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 6,040 | +6.0% | Form 10-K (filed 2026-02-13) ↗ |
| FY2022 | Dec 31, 2022 | 5,699 | +7.8% | Form 10-K (filed 2025-02-13) ↗ |
| FY2021 | Dec 31, 2021 | 5,287 | +9.5% | Form 10-K (filed 2024-02-15) ↗ |
| FY2020 | Dec 31, 2020 | 4,826 | +57.7% | Form 10-K (filed 2023-02-10) ↗ |
| FY2019 | Dec 31, 2019 | 3,060 | +29.4% | Form 10-K (filed 2022-02-09) ↗ |
| FY2018 | Dec 31, 2018 | 2,365 | +19.0% | Form 10-K (filed 2021-02-11) ↗ |
| FY2017 | Dec 31, 2017 | 1,987 | +50.3% | Form 10-K (filed 2020-02-13) ↗ |
| FY2016 | Dec 31, 2016 | 1,322 | +73.2% | Form 10-K (filed 2019-02-13) ↗ |
| FY2015 | Dec 31, 2015 | 763 | +111.4% | Form 10-K (filed 2018-02-15) ↗ |
| FY2014 | Dec 31, 2014 | 361 | -59.7% | Form 10-K (filed 2015-02-13) ↗ |
| FY2013 | Dec 31, 2013 | 897 | -34.7% | Form 10-K (filed 2014-02-11) ↗ |
| FY2012 | Dec 31, 2012 | 1,374 | -1.2% | Form 10-K (filed 2013-03-01) ↗ |
| FY2011 | Dec 31, 2011 | 1,390 | +869.0% | Form 10-K (filed 2012-02-22) ↗ |
| FY2010 | Dec 31, 2010 | 143 | +40.7% | Form 10-K (filed 2012-02-22) ↗ |
| FY2009 | Dec 31, 2009 | 102 | – | Form 10-K (filed 2012-02-22) ↗ |
Breakdown
What makes up net product revenues by geography
Cite this data
StockData. (2026). Vertex Pharmaceuticals Net product revenues by geography ($M), annual FY2009–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/rev-geo-hdr
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.